Gilissen LPL - Search Results

1

Standard of Care Versus Octreotide in Angiodysplasia-Related Bleeding (the OCEAN Study): A Multicenter Randomized Controlled Trial.

Goltstein LCMJ, Grooteman KV, Bernts LHP, Scheffer RCH, Laheij RJF, Gilissen LPL, Schrauwen RWM, Talstra NC, Zuur AT, Braat H, Hadithi M, Brouwer JT, Nagengast WB, Oort FA, Tenthof van Noorden J, Kievit W, van Geenen EJM, Drenth JPH. Goltstein LCMJ, et al. Among authors: gilissen lpl. Gastroenterology. 2024 Apr;166(4):690-703. doi: 10.1053/j.gastro.2023.12.020. Epub 2023 Dec 28. Gastroenterology. 2024. PMID: 38158089 Free article. Clinical Trial.

2

Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.

Coenen MJ, de Jong DJ, van Marrewijk CJ, Derijks LJ, Vermeulen SH, Wong DR, Klungel OH, Verbeek AL, Hooymans PM, Peters WH, te Morsche RH, Newman WG, Scheffer H, Guchelaar HJ, Franke B; TOPIC Recruitment Team. Coenen MJ, et al. Gastroenterology. 2015 Oct;149(4):907-17.e7. doi: 10.1053/j.gastro.2015.06.002. Epub 2015 Jun 11. Gastroenterology. 2015. PMID: 26072396 Clinical Trial.

3

Endoscopic full-thickness resection (eFTR) of colorectal lesions: results from the Dutch colorectal eFTR registry.

Zwager LW, Bastiaansen BAJ, Bronzwaer MES, van der Spek BW, Heine GDN, Haasnoot KJC, van der Sluis H, Perk LE, Boonstra JJ, Rietdijk ST, Wolters HJ, Weusten BLAM, Gilissen LPL, Ten Hove WR, Nagengast WB, Bekkering FC, Schwartz MP, Terhaar Sive Droste JS, Vlug MS, Houben MHMG, Rando Munoz FJ, Seerden TCJ, Beaumont H, de Ridder R, Dekker E, Fockens P; Dutch eFTR Group. Zwager LW, et al. Among authors: gilissen lpl. Endoscopy. 2020 Nov;52(11):1014-1023. doi: 10.1055/a-1176-1107. Epub 2020 Jun 4. Endoscopy. 2020. PMID: 32498100 Clinical Trial.

4

Antibacterial gauzes are effective in preventing infections after percutaneous endoscopic gastrostomy placement: a retrospective analysis.

Strijbos D, Schoon EJ, Curvers W, Friederich P, Flink HJ, Stronkhorst A, Gilissen LP. Strijbos D, et al. Eur J Gastroenterol Hepatol. 2016 Mar;28(3):297-304. doi: 10.1097/MEG.0000000000000561. Eur J Gastroenterol Hepatol. 2016. PMID: 26735159

5

Better survival of renal cell carcinoma in patients with inflammatory bowel disease.

Derikx LA, Nissen LH, Drenth JP, van Herpen CM, Kievit W, Verhoeven RH, Mulders PF, Hulsbergen-van de Kaa CA, Boers-Sonderen MJ, van den Heuvel TR, Pierik M, Nagtegaal ID, Hoentjen F; Dutch Initiative on Crohn and Colitis; PALGA Group; IBD/RCC Group. Derikx LA, et al. Oncotarget. 2015 Nov 10;6(35):38336-47. doi: 10.18632/oncotarget.5186. Oncotarget. 2015. PMID: 26447542 Free PMC article.

6

A Systematic Review and Meta-Analysis on Outcomes and Complications of Percutaneous Endoscopic Versus Radiologic Gastrostomy for Enteral Feeding.

Strijbos D, Keszthelyi D, Bogie RMM, Gilissen LPL, Lacko M, Hoeijmakers JGJ, van der Leij C, de Ridder R, de Haan MW, Masclee AAM. Strijbos D, et al. Among authors: gilissen lpl. J Clin Gastroenterol. 2018 Oct;52(9):753-764. doi: 10.1097/MCG.0000000000001082. J Clin Gastroenterol. 2018. PMID: 29924079

7

The prevalence of nodular regenerative hyperplasia of the liver in long-term thiopurine-treated inflammatory bowel disease patients.

Gilissen LPL, Tajzai R, Romberg M, Pierik M, Stronkhorst A, Steenhuisen K, Van Bodegraven A, Daniels A, Wong D. Gilissen LPL, et al. Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e102-e107. doi: 10.1097/MEG.0000000000001980. Eur J Gastroenterol Hepatol. 2021. PMID: 33136726

8

On tolerability and safety of a maintenance treatment with 6-thioguanine in azathioprine or 6-mercaptopurine intolerant IBD patients.

de Boer NK, Derijks LJ, Gilissen LP, Hommes DW, Engels LG, de-Boer SY, den Hartog G, Hooymans PM, Mäkelburg AB, Westerveld BD, Naber AH, Mulder CJ, de Jong DJ. de Boer NK, et al. World J Gastroenterol. 2005 Sep 21;11(35):5540-4. doi: 10.3748/wjg.v11.i35.5540. World J Gastroenterol. 2005. PMID: 16222751 Free PMC article.

9

Risk Factors and Clinical Outcomes of Head and Neck Cancer in Inflammatory Bowel Disease: A Nationwide Cohort Study.

Nissen LHC, Derikx LAAP, Jacobs AME, van Herpen CM, Kievit W, Verhoeven R, van den Broek E, Bekers E, van den Heuvel T, Pierik M, Rahamat-Langendoen J, Takes RP, Melchers WJG, Nagtegaal ID, Hoentjen F; Dutch Initiative on Crohn and Colitis (ICC); Dutch Head and Neck Society, PALGA group; IBD/HNC group. Nissen LHC, et al. Inflamm Bowel Dis. 2018 Aug 16;24(9):2015-2026. doi: 10.1093/ibd/izy096. Inflamm Bowel Dis. 2018. PMID: 30759216

10

Short article: The effect of implementation of a treatment algorithm for infliximab on remission rates and drug costs in inflammatory bowel disease patients.

Taks M, Pijls PA, Derijks LJ, Ten Broeke R, Grouls RJ, Curvers J, Gilissen LP. Taks M, et al. Eur J Gastroenterol Hepatol. 2017 Feb;29(2):169-173. doi: 10.1097/MEG.0000000000000763. Eur J Gastroenterol Hepatol. 2017. PMID: 27749780 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page